A post hoc analysis from the RECOVER study (Randomized Evaluation of the 24-hour Coverage: Efficacy of Rotigotine) suggested that patients with Parkinson's disease who used Neupro® (rotigotine) may experience improvements in key markers of mood/cognition, such as taking interest in surroundings and getting pleasure out of life 1.

Additional data presented from a one year open label follow-up of RECOVER supported the continuing benefits of rotigotine on motor, sleep and nocturnal symptoms2,3.

These data were presented at the 15th International Congress of Parkinson's disease and Movement disorders in Toronto, Canada (June 5-9, 2011).

Effects of rotigotine on mood and anhedonia

A post hoc analysis of the RECOVER study suggested that rotigotine may be associated with improvements compared with placebo on 4 of the 7 individual items in the mood/cognition domain of the Parkinson's Disease Non-Motor Symptom Scale (PDNMSS). These were loss of interest in surroundings (p